Vera Therapeutics, Inc.
VERA
$22.57
-$0.04-0.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.05% | -19.04% | 6.88% | -38.34% | -18.76% |
| Total Depreciation and Amortization | 40.00% | 54.55% | 129.17% | 60.00% | 36.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.96% | 35.09% | 27.36% | 39.50% | -12.46% |
| Change in Net Operating Assets | 241.79% | -1,196.43% | -112.42% | -4.57% | 171.28% |
| Cash from Operations | -0.72% | -38.85% | -6.23% | -48.84% | 26.75% |
| Capital Expenditure | -11.23% | 71.01% | -171.01% | -167.42% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 85.45% | 107.02% | -672.53% | 270.69% | 89.70% |
| Cash from Investing | 86.36% | 106.92% | -677.77% | 268.97% | 89.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -69.73% | -99.56% | 46,084.97% | -78.13% | -98.83% |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 1,223.22% | -99.53% | 44,007.58% | -78.51% | -98.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.11% | -157.43% | 2,911.98% | 104.93% | -287.93% |